ブラジルのプロポリスエタノール抽出物に基づくヒドロゲルの配方と評価は,糖尿病の傷の治癒を促進するために使用されます

Huanglin Huo¹, Zhenhua Zhou¹, Rongxiang Guo²

¹The First Affiliated Hospital of Guangdong Pharmaceutical University, MOE Key Laboratory of Glucolipid Metabolic Disorder, Guangdong Provincial TCM Key Laboratory for Metabolic Diseases, Traditional Chinese Medicine Research Institute (Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases), Guangdong Pharmaceutical University, Guangzhou, 510006, China.

BMC biotechnology

|February 21, 2026

まとめ

新しいヒドロゲル敷き,EEP/PSは,炎症を軽減し,感染と闘い,治癒を促進することによって,糖尿病の傷を効果的に治療します. このバイオマテリアルは,先進的な糖尿病の傷口ケアに期待を寄せている.

科学分野:

バイオマテリアル科学バイオマテリアル科学
傷の癒し傷の癒し
再生医学は,再生医療である.

背景:

糖尿病性創傷は,炎症,感染リスク,および不良の血管形成 (血管新生) により,重大な臨床的課題となっています.
既存の治療法では,これらの傷の複雑なマイクロ環境を効果的に対処することができないことが多い.

研究の目的:

糖尿病の傷を治療するための多機能ヒドロゲル包帯 (EEP/PS) の開発と評価.
抗酸化剤,抗炎症剤,抗菌剤,および治療効果を含むヒドロゲルの性質を評価する.

主な方法:

プルーラン,ブラジル産プロポリスのエタノール抽出物,ポリビニールアルコールを用いて,ヒドロゲルドレスメント (EEP/PS) を合成した.
インビトロ試験では,抗酸化,抗炎症 (サイトカインダウンレギュレーション),抗菌 (E. coli,S. aureusに対する) 効果を評価した.
In vivo研究では,糖尿病のラットモデルを用いて,傷の閉塞,再表皮化,コラーゲンの堆積,血管新生,炎症を評価した.

主要な成果:

EEP/PSは,多孔構造,良好な機械特性,熱安定性,持続的な放出を示した.
ハイドロゲルは強力な抗酸化活性を示し,細胞の移動を促進し,主要な炎症性サイトカイン (TNF-α,IL-6,IL-1β) を抑制しました.
EEP/PSは,癒しのメカニズムを促進し,炎症を軽減し,血静と生物互換性を示し,糖尿病の創傷閉塞を加速しました.

結論:

多機能のEEP/PSヒドロゲル包帯は,糖尿病性創傷の治療に重要な可能性を示しています.
その組み合わせた性質は,糖尿病の傷の治癒における主要な課題に対処し,臨床応用のための強力な翻訳的展望を示しています.

キーワード:

抗菌剤抗菌剤抗菌剤抗菌剤抗菌剤抗菌剤ブラジルのプロポリス.糖尿病による傷口.ハイドロゲル製の水素ゲルです.炎症炎症炎症炎症炎症

さらに関連する動画

05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.9K

03:57

Author Spotlight: Exploring Corneal Innate Immunity and Delayed Wound Healing in Diabetic Patients

Published on: January 10, 2025

25.3K

関連する概念動画

01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...

01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...

01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

関連する実験動画